New biomarkers predict outcome of cancer immunotherapy
Researchers have identified biomarkers in the blood that make it possible to predict whether cancer patients will respond positively to immunotherapy. Patients for whom therapy does not work can thus be treated using different methods at an earlier stage. …read more
